For example, Leyten et al. [35] developed an 8-gene panel and a 3-gene panel that can identify patients with aggressive prostate cancer; notably HOXC6 and HOXC4 were in the 8-gene panel whereas HOXC6 remained as an important classifier in the smaller 3-gene panel. This evidence concerns the gene HOXC6 and prostate carcinoma.